Derm-Biome Pharmaceuticals Announces Collaboration with Massachusetts General Hospital in Skin Cancer Study
November 28, 2023 10:00 ET
|
Derm-Biome Pharmaceuticals, Inc
VANCOUVER, British Columbia, Nov. 28, 2023 (GLOBE NEWSWIRE) -- Derm-Biome Pharmaceuticals Inc, a Vancouver based biopharmaceutical company with a focus on skin disease, is excited to announce that...
Immunocore Reports Third Quarter 2023 Financial Results and Provides Business Update
November 07, 2023 07:00 ET
|
Immunocore Holdings Limited
Immunocore Reports Third Quarter 2023 Financial Results and Provides Business Update KIMMTRAK net revenues of £49.7 million ($60.7 million) in Q3 2023, maintaining strong momentum in major...
Skin Cancer Treatment Market to Surpass USD 18.06 Billion by 2030 Driven by Rising Incidence of Skin Cancer and Globalization of Healthcare | Research by SNS Insider
October 16, 2023 09:05 ET
|
SNS Insider pvt ltd
Pune, Oct. 16, 2023 (GLOBE NEWSWIRE) -- “The Skin Cancer Treatment Market, as per the SNS Insider report, achieved a value of USD 9.98 Billion and is projected to attain USD 18.06 Billion by 2030,...
Mineral Sunscreen Market Revenue to Reach USD 1.6 Bn by 2031, growing at a CAGR of 5.4%: Reveals TMR Study
May 08, 2023 12:30 ET
|
Transparency Market Research
Wilmington, Delaware, United States, May 08, 2023 (GLOBE NEWSWIRE) -- The global mineral sunscreen market was valued at USD 960.0 Mn in 2021 and is anticipated to reach USD 1.6 Bn by 2031, expanding...
CLINUVEL Launches CYACÊLLE, Next Generation Solar Care
February 28, 2023 18:58 ET
|
Clinuvel Pharmaceuticals Limited
UV, HEV protection for individuals at high risk of photoageing and skin cancer MELBOURNE, Australia, March 01, 2023 (GLOBE NEWSWIRE) -- CLINUVEL (ASX: CUV) (Börse Frankfurt: UR9) (ADR Level...
CLINUVEL Drug Significantly Reduces Critical UV Skin Damage in Fair-Skinned Individuals
February 01, 2023 19:14 ET
|
Clinuvel Pharmaceuticals Limited
MELBOURNE, Australia, Feb. 02, 2023 (GLOBE NEWSWIRE) -- Results released today from a clinical study have shown that the drug afamelanotide can reduce critical skin damage caused by ultraviolet (UV)...
CLINUVEL Trial Results Show Drug Reduces DNA Damage
January 15, 2023 18:23 ET
|
Clinuvel Pharmaceuticals Limited
MELBOURNE, Australia, Jan. 16, 2023 (GLOBE NEWSWIRE) -- Results from a clinical trial in a genetic DNA repair disorder show that a new drug – afamelanotide – may be able to reduce the development of...
Alpha Tau Medical Announces Third Quarter 2022 Financial Results and Provides Corporate Update
November 22, 2022 16:02 ET
|
Alpha Tau Medical Ltd.
JERUSALEM, Nov. 22, 2022 (GLOBE NEWSWIRE) -- Alpha Tau Medical Ltd. (Nasdaq: DRTS and DRTSW), ("Alpha Tau" or the “Company”), the developer of the innovative alpha-radiation cancer therapy Alpha...
The GetSkinHelp WalkING Clinic will be travelling through the streets of Downtown Toronto and help people get the medical attention they need and are waiting for
November 14, 2022 07:07 ET
|
Skinopathy
TORONTO, Nov. 14, 2022 (GLOBE NEWSWIRE) -- Skinopathy, the company behind GetSkinHelp, are helping people avoid months of waiting thanks to The GetSkinHelp WalkING Clinic which will bring the doctor...
Derm-Biome Pharmaceuticals, Inc. reports positive preclinical data in melanoma and squamous cell carcinoma, initiates a program aimed at advancing topical therapies for skin cancer to the clinic
October 12, 2022 10:00 ET
|
Derm-Biome Pharmaceuticals, Inc
VANCOUVER, British Columbia, Oct. 12, 2022 (GLOBE NEWSWIRE) -- Derm-Biome Pharmaceuticals, Inc, a Vancouver based preclinical biopharmaceutical company focused on skin health and healthy aging, has...